Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

102
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
102
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

122
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
122
Antibiotic Selection00:57

Antibiotic Selection

57.4K
Overview
57.4K
Standard Precaution01:26

Standard Precaution

2.5K
Standard precautions are the minimum infection control safeguards used while caring for all patients, irrespective of their disease condition. They help prevent the spread of common infectious microorganisms to healthcare workers, patients, and visitors in all healthcare settings.
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...
2.5K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

102
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
102
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

3.4K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
3.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Clinical Case of Treatment-Emergent Acinetobacter baumannii Non-Susceptibility to Sulbactam-Durlobactam.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

Validation of an ICD-10-based algorithm for identifying inappropriate antibiotic prescribing for pediatric outpatients.

Infection control and hospital epidemiology·2026
Same author

Are bactericidal antibiotics necessary to effectively treat bloodstream infections?

CMI communications·2026
Same author

Standardized numbering and alignment of the KPC family of β-lactamases.

Antimicrobial agents and chemotherapy·2026
Same author

Malaria in Children at 9 US Hospitals: 2016-2023.

Pediatrics·2026
Same author

Comparative <i>in vitro</i> activity of aztreonam-avibactam and aztreonam plus ceftazidime-avibactam against <i>Stenotrophomonas maltophilia</i> complex.

Antimicrobial agents and chemotherapy·2026

Related Experiment Video

Updated: Nov 17, 2025

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

13.2K

Policy Statement: Antibiotic Stewardship in Pediatrics.

Jeffrey S Gerber1,2, Mary Anne Jackson3, Pranita D Tamma4

  • 1Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.

Journal of the Pediatric Infectious Diseases Society
|February 17, 2021
PubMed
Summary

Antibiotic stewardship programs (ASPs) are crucial for combating antibiotic resistance. This policy statement offers specific guidance for pediatric antibiotic stewardship to optimize treatment and minimize harm.

Keywords:
antibiotic resistanceantimicrobial stewardshippediatrics

More Related Videos

Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
09:26

Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung

Published on: January 22, 2021

7.3K
A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

14.9K

Related Experiment Videos

Last Updated: Nov 17, 2025

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

13.2K
Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
09:26

Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung

Published on: January 22, 2021

7.3K
A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

14.9K

Area of Science:

  • Public Health
  • Infectious Diseases
  • Pharmacology

Background:

  • Antibiotic overuse fuels antibiotic resistance, a significant public health threat.
  • Antibiotic stewardship programs (ASPs) aim to optimize antibiotic prescribing.
  • Pediatric populations have unique considerations for antibiotic therapy.

Purpose of the Study:

  • To provide specific guidance for pediatric antibiotic stewardship programs (ASPs).
  • To outline essential components and activities for effective inpatient and outpatient ASPs.
  • To address the rationale, implementation, and evaluation of pediatric ASPs.

Main Methods:

  • Policy statement development based on existing evidence and expert consensus.
  • Review of common pediatric infectious conditions and treatment recommendations.
  • Discussion of essential personnel, infrastructure, and activities for ASPs.

Main Results:

  • Provides a framework for establishing and evaluating pediatric ASPs.
  • Highlights key differences in pediatric versus adult antibiotic considerations.
  • Offers guidance on appropriate antibiotic selection, dose, duration, and route for children.

Conclusions:

  • Effective pediatric antibiotic stewardship is vital to combat resistance and improve outcomes.
  • Implementation of comprehensive ASPs is recommended for both inpatient and outpatient settings.
  • Further research is needed to address knowledge gaps in pediatric antibiotic use.